文献速递乳腺癌放疗放疗物理与技术

早期乳腺癌术后质子与光子放疗急性副作用的随机对照试验亚组分析

Acute Radiation Side Effects of Proton Versus Photon Therapy Following Surgery for Early Breast Cancer, a Substudy of the Randomized Controlled Danish Breast Cancer Group Proton Trial.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2026-08-14

该研究为丹麦乳腺癌协作组质子试验的预设计亚组分析,纳入167例(186个治疗乳房)需辅助放疗的浸润性乳腺癌或导管原位癌患者,1:1随机接受中度大分割质子治疗(PT)或光子放疗(γRT)。结果显示PT组2-3级皮炎、瘙痒和局部疼痛发生率更高但均为暂时性,呼吸症状、吞咽困难、疲劳及手臂/肩部症状两组相似,无因副作用中断治疗。

要点

  • PT组2-3级皮炎发生率为71%,γRT组为20%,差异显著但均在峰值后2-4周内消退。
  • PT组瘙痒(20% vs 5%)和局部疼痛(17% vs 4%)发生率高于γRT组。
  • 呼吸症状、吞咽困难、疲劳及手臂/肩部症状两组相似且轻微,无治疗中断。

核心结论

  • 乳腺癌放疗急性副作用以皮肤相关为主,PT组发生率高于γRT组但均为暂时性。
  • 非皮肤相关副作用包括呼吸症状、疲劳和手臂/肩部症状在PT与γRT间相当。
  • 采用现代技术及中度大分割时,PT是浸润性乳腺癌或导管原位癌辅助治疗的可行且临床可接受方案。

研究设计与样本

  • 丹麦乳腺癌协作组质子试验的预设计亚组分析,该试验为全国性3期随机对照试验。
  • 纳入167例(186个治疗乳房)浸润性乳腺癌或导管原位癌患者,按1:1随机分配至PT组(84例)或γRT组(83例)。
  • 入组条件为基于γRT计划CT预期接受高心脏和/或肺剂量的辅助放疗患者。
  • 急性副作用在放疗期间及治疗后6个月内前瞻性评估。

主要发现

  • 皮肤相关副作用在第5周达峰值,PT组2-3级皮炎发生率为71%,γRT组为20%。
  • PT组瘙痒发生率为20%,γRT组为5%;PT组局部疼痛发生率为17%,γRT组为4%。
  • 所有2-3级皮肤相关副作用均为暂时性,峰值后2-4周内消退至0-1级。
  • 呼吸症状、吞咽困难及疲劳轻微且两组相似,临床相关手臂/肩部症状罕见。
  • 未观察到因副作用中断治疗的情况。

关键数值与推荐

  • PT组2-3级皮炎71% vs γRT组20%,瘙痒20% vs 5%,局部疼痛17% vs 4%。
  • 所有2-3级皮肤相关副作用在峰值后2-4周内消退至0-1级。
  • 呼吸症状、吞咽困难、疲劳及手臂/肩部症状两组相似且轻微。
  • 无因副作用中断治疗。

临床怎么用

  • 对于基于光子计划预期高心脏和/或肺剂量的乳腺癌辅助放疗患者,PT是可行的治疗选择。
  • 应告知患者PT后急性皮肤相关副作用(皮炎、瘙痒、局部疼痛)发生率较高但为暂时性。
  • PT后非皮肤相关副作用与γRT相当,无需额外担心呼吸、疲劳或手臂/肩部症状。

局限性

  • 原文未报告

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Proton therapy (PT) is associated with favorable dosimetric characteristics compared with photon radiation therapy (γRT) in invasive breast cancer; however, clinical evidence on acute toxicity remains limited. This study aimed to compare acute treatment-related side effects between moderately hypofractionated PT and γRT in breast cancer. METHODS AND MATERIALS: The Danish Breast Cancer Group Proton trial-acute side effects was a preplanned substudy of the national, phase 3 randomized trial, the Danish Breast Cancer Group Proton trial. Patients with invasive breast cancer or ductal carcinoma in situ scheduled for adjuvant radiation therapy (RT), who were expected to receive a high cardiac and/or pulmonary dose based on γRT planning computed tomography scan, were randomized 1:1 to PT or γRT. Acute side effects were prospectively assessed during RT and up to 6 months posttreatment. Outcomes included skin-related side effects, respiratory symptoms, dysphagia, fatigue, and arm/shoulder side effects. RESULTS: A total of 167 patients (186 treated breasts) were included (PT 84 and γRT 83). Skin-related side effects peaked at week 5, with higher grade 2 to 3 dermatitis (71% PT vs 20% γRT), pruritus (20% vs 5%), and local pain (17% vs 4%) after PT compared with γRT. All skin-related grade 2 to 3 side effects were transient, resolving to grade 0 to 1 within 2 to 4 weeks after peaking. Respiratory symptoms, dysphagia, and fatigue were mild and similar between groups. Clinically relevant arm/shoulder morbidity was rare. No treatment discontinuations because of side effects were observed. CONCLUSIONS: Acute side effects after breast cancer RT were primarily skin-related, higher but transient after PT compared with γRT. Non-skin-related side effects, including respiratory symptoms, fatigue, and arm/shoulder morbidity, were comparable between PT and γRT. These prospective data, using modern techniques and moderate hypofractionation, suggest that PT is a feasible and clinically acceptable treatment approach for adjuvant treatment of invasive breast cancer or ductal carcinoma in situ, while acknowledging the higher incidence of transient acute skin-related side effects.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Høgsbjerg KW, Petersen SE, Maae E, et al. Acute Radiation Side Effects of Proton Versus Photon Therapy Following Surgery for Early Breast Cancer, a Substudy of the Randomized Controlled Danish Breast Cancer Group Proton Trial. Int J Radiat Oncol Biol Phys. 2026. PMID: 42600707. doi:10.1016/j.ijrobp.2026.08.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。